Published in J Pediatr on April 01, 1978
Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62
In vivo distribution of human milk leucocytes after ingestion by newborn baboons. Arch Dis Child (1989) 1.55
Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol (2002) 1.19
Immunologic and genetic factors influencing reproduction. A review. Am J Pathol (1979) 1.12
Human milk stimulates B cell function. Arch Dis Child (1985) 1.01
Antibody content of rabbit milk and serum following inhalation or ingestion of respiratory syncytial virus and bovine serum albumin. Clin Exp Immunol (1982) 0.98
Human milk contains proteins that stimulate and suppress T lymphocyte proliferation. Clin Exp Immunol (1990) 0.95
Lymphokine production by human milk lymphocytes. Infect Immun (1981) 0.92
Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes. J Virol (2010) 0.92
Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission. AIDS (2012) 0.90
Serum-free growth of normal and transformed fibroblasts in milk: differential requirements for fibronectin. J Cell Biol (1981) 0.86
Maternal to neonatal transmission of T-cell mediated immunity to Trichinella spiralis during lactation. Immunology (1989) 0.84
Breast milk lymphocyte response to K1 antigen of Escherichia coli. Infect Immun (1980) 0.81
Impaired production and lack of secretion of interleukin 1 by human breast milk macrophages. Clin Exp Immunol (1988) 0.80
Colostral antibody-mediated and cell-mediated immunity contributes to innate and antigen-specific immunity in piglets. Dev Comp Immunol (2013) 0.80
Bactericidal mechanisms of human breast milk leukocytes. Infect Immun (1980) 0.80
Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta. Immunology (1998) 0.76
Immunoglobulins A and G2a in milks of protein- and calorie-restricted dams. J Clin Microbiol (1987) 0.75
Infant feeding in the Third World. Postgrad Med J (1986) 0.75
A factor present in human milk, but not colostrum, which is cytotoxic for human lymphocytes. Clin Exp Immunol (1984) 0.75
Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol (1969) 3.49
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med (1971) 3.13
Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med (1971) 2.62
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Respiratory syncytial virus. Curr Probl Pediatr (1993) 1.93
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J (1990) 1.88
Potential spectrum of etiological agents of viral enteritis in hospitalized infants. J Clin Microbiol (1983) 1.85
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis (2001) 1.78
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr (1992) 1.70
Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol (1977) 1.69
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr (1980) 1.63
Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol (1991) 1.60
Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis (1989) 1.55
Rubella-virus infection in juvenile rheumatoid arthritis. Lancet (1975) 1.52
Arthritis associated with induced rubella infection. J Immunol (1971) 1.51
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
Enzyme immunoassay with monoclonal antibodies for the detection of rotavirus in stool specimens. J Infect Dis (1985) 1.39
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis (1979) 1.38
Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun (1991) 1.38
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol (1996) 1.35
Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis (1990) 1.34
Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child (1981) 1.34
Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis (1977) 1.33
Immunologic aspects of hepatitis-associated antigen and antibody in human body fluids. J Immunol (1973) 1.32
Age-dependent rotavirus-enterocyte interactions. Proc Soc Exp Biol Med (1982) 1.31
Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis (1997) 1.31
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
The human female reproductive tract: immunohistological localization of gamma A, gamma G, gamma M, secretory "piece," and lactoferrin. Am J Obstet Gynecol (1970) 1.28
The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol (1998) 1.28
Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol (1982) 1.28
Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol (1987) 1.27
Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol (1990) 1.27
Rapid detection of poliovirus by reverse transcription and polymerase chain amplification: application for differentiation between poliovirus and nonpoliovirus enteroviruses. J Clin Microbiol (1993) 1.26
Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med (1990) 1.26
Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol (1987) 1.23
Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr (1979) 1.23
Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol (1991) 1.22
Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr (1986) 1.21
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol (1988) 1.20
Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol (1988) 1.20
Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol (1984) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Poliovirus antibody response in patients with acute leukemia. J Pediatr (1971) 1.16
The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med (1980) 1.15
The role of immunoglulins in the mechanism of mucosal immunity to virus infection. Pediatr Clin North Am (1970) 1.13
Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation. J Pediatr (1978) 1.13
The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res (1988) 1.12
Mucosal immune response to poliovirus vaccines in childhood. Rev Infect Dis (1984) 1.12
Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man. J Med Virol (1981) 1.11
Natural history of parainfluenza virus infection in childhood. J Pediatr (1982) 1.11
Otitis media in children: local immune response to nontypeable Haemophilus influenzae. Infect Immun (1989) 1.10
Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand (1976) 1.09
Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J Med Virol (1989) 1.08
Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis (1982) 1.08
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol (1992) 1.06
Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. J Pediatr (1979) 1.06
Viral vaccination via the mucosal routes. Rev Infect Dis (1980) 1.05
Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans. J Infect Dis (1978) 1.05
Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis (1993) 1.03
Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans. Infect Immun (1979) 1.03
Rubella immunization of volunteers via the respiratory tract. Infect Immun (1973) 1.02
Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites. J Gen Virol (1987) 1.02
Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med (1968) 1.02
Bronchomammary axis in the immune response to respiratory syncytial virus. J Pediatr (1981) 1.00
Mechanisms underlying the development of meningitis or epiglottitis in children after Haemophilus influenzae type b bacteremia. J Infect Dis (1985) 1.00
Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol (1991) 0.99
Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J Infect Dis (1983) 0.99
Interaction of polymorphonuclear leukocytes and viruses in humans: adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells. J Virol (1984) 0.99
Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers. Clin Exp Immunol (1979) 0.98
Antibody content of rabbit milk and serum following inhalation or ingestion of respiratory syncytial virus and bovine serum albumin. Clin Exp Immunol (1982) 0.98
Distribution and engraftment patterns of human tonsillar mononuclear cells and immunoglobulin-secreting cells in mice with severe combined immunodeficiency: role of the Epstein-Barr virus. Int Arch Allergy Appl Immunol (1991) 0.98
Development of respiratory mucosal tolerance during Haemophilus influenzae type B infection in infancy. J Immunol (1984) 0.96
Effect of breast feeding on the development of anti-idiotype antibody response to F glycoprotein of respiratory syncytial virus in infant mice after post-partum maternal immunization. J Immunol (1989) 0.96
Immunohistologic localization of immunoglobulins, secretory component, and lactoferrin in the developing human fetus. Proc Soc Exp Biol Med (1972) 0.96
Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate. J Med Virol (1996) 0.95
Characteristics of secretory immune system in human middle ear: implications in otitis media. J Immunol (1974) 0.95
Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus. Clin Exp Immunol (1985) 0.95
Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection. J Clin Microbiol (1989) 0.95
Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus. J Clin Microbiol (1981) 0.94
Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. Int Arch Allergy Appl Immunol (1988) 0.94
Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood. J Pediatr (1982) 0.94
Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med (1991) 0.94
Urinary tract infections in childhood: an update. J Pediatr (1985) 0.94